The company's financial position has weakened, with total equity deteriorating to a negative $6.3B and total debt climbing to $49.8B as of 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 16.05B | 13.56B | 16.41B | 14.93B | 13.64B | 13.54B | 12.33B | 11.2B | 10.21B | 9.98B | 9.09B | 9.23B | 8.93B | 8.04B | 7.76B | 7.23B | 6.92B | 6.58B | 6.3B | 6.21B | 6.08B | 5.21B | 4.68B | 4.82B | 4.5B | 4.14B | 4.45B | 3.6B | 3.86B | 4.42B | 4.41B |
| Cash & Short-Term Investments | 940M | 1.04B | 2.02B | 935M | 908M | 1.45B | 1.79B | 621M | 502M | 732M | 646M | 741M | 566M | 414M | 705M | 373M | 411M | 312M | 465M | 393M | 634M | 336M | 258M | 115M | 161M | 85M | 314M | 190M | 297M | 110M | 113M |
| Cash Only | 940M | 1.04B | 1.93B | 935M | 908M | 1.45B | 1.79B | 621M | 502M | 732M | 646M | 741M | 566M | 414M | 705M | 373M | 411M | 312M | 465M | 393M | 634M | 336M | 129M | 115M | 161M | 85M | 314M | 190M | 297M | 110M | 113M |
| Short-Term Investments | 0 | 0 | 88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 11.32B | 10.87B | 10.75B | 9.96B | 8.89B | 8.1B | 7.05B | 7.38B | 6.79B | 6.5B | 5.83B | 5.89B | 5.69B | 5.21B | 4.67B | 4.53B | 3.83B | 3.69B | 3.78B | 3.9B | 3.71B | 3.33B | 3.08B | 3.1B | 2.79B | 2.51B | 2.41B | 2.05B | 2.25B | 3.05B | 2.84B |
| Days Sales Outstanding | 51.46 | 52.47 | 55.58 | 55.95 | 53.88 | 50.29 | 49.94 | 52.47 | 53.09 | 54.41 | 51.25 | 54.17 | 56.3 | 55.61 | 51.65 | 50.9 | 45.58 | 44.84 | 48.63 | 52.93 | 53.08 | 49.73 | 47.88 | 51.8 | 51.58 | 51.09 | 52.72 | 44.94 | 43.86 | 59.23 | 52.1 |
| Inventory | 1.68B | 1.65B | 1.74B | 2.02B | 2.07B | 1.99B | 2.02B | 1.85B | 1.73B | 1.57B | 1.5B | 1.44B | 1.28B | 1.18B | 1.09B | 1.05B | 897M | 802M | 737M | 710M | 669M | 616M | 577M | 520M | 462M | 423M | 396M | 383M | 434M | 452M | 441M |
| Days Inventory Outstanding | 12.59 | 13.63 | 15.13 | 18.73 | 20.37 | 19.99 | 88.32 | 79.58 | 81.85 | 78.48 | 79.13 | 79.13 | 74.55 | 72.08 | 69.34 | 74.28 | 66 | 60.13 | 58.23 | 58.96 | 56.5 | 54.49 | 53.99 | - | - | - | - | - | - | - | 21.35 |
| Other Current Assets | 2.11B | 0 | 1.9B | 2.01B | 1.78B | 2.01B | 1.46B | 1.35B | 1.19B | 1.17B | 1.11B | 1.16B | 1.39B | 1.24B | 1.3B | 1.27B | 1.78B | 1.77B | 1.32B | 1.21B | 1.07B | 931M | 1.14B | 1.09B | 1.09B | 1.12B | 1.33B | 973M | 887M | 807M | 806M |
| Total Non-Current Assets | 45.4B | 47.16B | 43.1B | 41.28B | 38.8B | 37.2B | 35.16B | 33.86B | 28.99B | 26.62B | 24.67B | 23.51B | 22.27B | 20.79B | 20.31B | 19.66B | 16.93B | 17.55B | 17.98B | 17.82B | 17.6B | 17.01B | 16.78B | 16.24B | 14.24B | 13.59B | 13.12B | 13.29B | 15.57B | 17.58B | 16.86B |
| Property, Plant & Equipment | 33.57B | 31.14B | 31.55B | 29.92B | 27.64B | 26.18B | 25.22B | 24.55B | 19.76B | 17.89B | 16.35B | 15.01B | 14.36B | 13.62B | 13.19B | 12.83B | 11.35B | 11.43B | 11.53B | 11.44B | 11.67B | 11.38B | 11.4B | 11.06B | 9.72B | 8.92B | 8.48B | 8.49B | 9.45B | 10.23B | 10.4B |
| Fixed Asset Turnover | 2.36x | 2.43x | 2.24x | 2.17x | 2.18x | 2.24x | 2.04x | 2.09x | 2.36x | 2.44x | 2.54x | 2.64x | 2.57x | 2.51x | 2.50x | 2.53x | 2.70x | 2.63x | 2.46x | 2.35x | 2.18x | 2.15x | 2.06x | 1.97x | 2.03x | 2.01x | 1.97x | 1.96x | 1.98x | 1.84x | 1.91x |
| Goodwill | 0 | 0 | 9.77B | 9.61B | 9.29B | 9.14B | 8.21B | 7.94B | 7.61B | 7.04B | 6.33B | 6.34B | 6.02B | 0 | 0 | 0 | 0 | 2.58B | 2.58B | 2.63B | 2.6B | 2.63B | 2.54B | 2.48B | 1.99B | 2.51B | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 10.5B | 10.29B | 323M | 339M | 359M | 403M | 369M | 330M | 342M | 359M | 374M | 393M | 399M | 5.9B | 5.54B | 5.25B | 2.69B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.41B | 2.05B | 2.25B | 3.05B | 2.84B |
| Long-Term Investments | 4.05B | 633M | 1.23B | 1.23B | 1.2B | 886M | 810M | 564M | 594M | 617M | 542M | 610M | 659M | 569M | 619M | 649M | 1.51B | 2.02B | 2.26B | 2.36B | 2.56B | 2.76B | 2.53B | 2.32B | 2.03B | 2.13B | 2.15B | 2.11B | 2.89B | 2.75B | 2.41B |
| Other Non-Current Assets | 326M | 5.09B | 230M | 184M | 298M | 598M | 546M | 480M | 690M | 710M | 1.07B | 1.16B | 620M | 703M | 969M | 931M | 1.38B | 1.53B | 1.61B | 1.39B | 762M | 244M | 313M | 378M | 487M | 486M | 330M | 368M | 318M | 1.08B | 550M |
| Total Assets | 61.45B | 60.72B | 59.51B | 56.21B | 52.44B | 50.74B | 47.49B | 45.06B | 39.21B | 36.59B | 33.76B | 32.74B | 31.2B | 28.83B | 28.07B | 26.9B | 23.85B | 24.13B | 24.28B | 24.02B | 23.68B | 22.23B | 21.46B | 21.06B | 18.74B | 17.73B | 17.57B | 16.89B | 19.43B | 22B | 21.27B |
| Asset Turnover | 1.27x | 1.25x | 1.19x | 1.16x | 1.15x | 1.16x | 1.09x | 1.14x | 1.19x | 1.19x | 1.23x | 1.21x | 1.18x | 1.19x | 1.18x | 1.21x | 1.29x | 1.25x | 1.17x | 1.12x | 1.08x | 1.10x | 1.09x | 1.04x | 1.05x | 1.01x | 0.95x | 0.99x | 0.96x | 0.86x | 0.94x |
| Asset Growth % | 9.03% | 2.03% | 5.87% | 7.2% | 3.34% | 6.85% | 5.4% | 14.92% | 7.14% | 8.4% | 3.1% | 4.95% | 8.21% | 2.69% | 4.38% | 12.77% | -1.16% | -0.61% | 1.06% | 1.48% | 6.52% | 3.54% | 1.91% | 12.39% | 5.7% | 0.92% | 4.04% | -13.09% | -11.69% | 3.43% | 6.94% |
| Total Current Liabilities | 19.26B | 16.35B | 15.18B | 12.65B | 9.9B | 9.58B | 8.7B | 7.76B | 7.57B | 6.16B | 5.83B | 5.52B | 5.48B | 5.7B | 6.17B | 5.55B | 4.27B | 4.31B | 3.91B | 3.85B | 3.58B | 3.9B | 3.17B | 3.17B | 3.74B | 3.18B | 4.14B | 3.33B | 3.56B | 2.77B | 2.95B |
| Accounts Payable | 4.81B | 4.66B | 4.28B | 4.23B | 4.24B | 4.11B | 3.54B | 2.9B | 2.58B | 2.61B | 2.32B | 2.17B | 2.04B | 1.8B | 1.77B | 1.6B | 1.54B | 1.46B | 1.37B | 1.37B | 1.42B | 1.48B | 855M | 877M | 809M | 755M | 693M | 657M | 784M | 929M | 790M |
| Days Payables Outstanding | 33.53 | 38.45 | 37.23 | 39.23 | 41.75 | 41.38 | 154.17 | 125.02 | 121.78 | 130.01 | 122.04 | 119.32 | 118.62 | 110.23 | 112.88 | 112.55 | 113.08 | 109.47 | 108.24 | 113.78 | 119.5 | 131.28 | 80 | - | - | - | - | - | - | - | 38.24 |
| Short-Term Debt | 8.53B | 6.74B | 4.7B | 2.42B | 370M | 237M | 209M | 145M | 788M | 200M | 216M | 233M | 338M | 786M | 1.44B | 1.41B | 592M | 846M | 404M | 308M | 293M | 586M | 486M | 665M | 446M | 807M | 1.12B | 1.16B | 1.07B | 132M | 201M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.9B | 2.42B | 910M | 867M | 794M | 549M | 547M | 528M | 459M | 67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46M |
| Current Ratio | 0.83x | 0.83x | 1.08x | 1.18x | 1.38x | 1.41x | 1.42x | 1.44x | 1.35x | 1.62x | 1.56x | 1.67x | 1.63x | 1.41x | 1.26x | 1.30x | 1.62x | 1.52x | 1.61x | 1.61x | 1.70x | 1.34x | 1.48x | 1.52x | 1.20x | 1.30x | 1.08x | 1.08x | 1.09x | 1.60x | 1.50x |
| Quick Ratio | 0.75x | 0.73x | 0.97x | 1.02x | 1.17x | 1.21x | 1.18x | 1.20x | 1.12x | 1.36x | 1.30x | 1.41x | 1.40x | 1.20x | 1.08x | 1.11x | 1.41x | 1.34x | 1.42x | 1.43x | 1.51x | 1.18x | 1.29x | 1.36x | 1.08x | 1.17x | 0.98x | 0.96x | 0.96x | 1.43x | 1.35x |
| Cash Conversion Cycle | 30.52 | 27.65 | 33.48 | 35.45 | 32.49 | 28.9 | -15.91 | 7.02 | 13.16 | 2.87 | 8.35 | 13.98 | 12.23 | 17.46 | 8.11 | 12.63 | -1.5 | -4.49 | -1.38 | -1.88 | -9.92 | -27.05 | 21.87 | - | - | - | - | - | - | - | 35.21 |
| Total Non-Current Liabilities | 45.17B | 47.14B | 43.78B | 42.5B | 42.61B | 39.67B | 35.89B | 37.87B | 34.56B | 35.43B | 33.56B | 33.27B | 32.22B | 30.06B | 30.24B | 28.36B | 30.38B | 27.8B | 29.63B | 29.78B | 30.57B | 12.64B | 13.07B | 11.01B | 8.69B | 9.22B | 8.45B | 7.17B | 7.52B | 11.14B | 8.88B |
| Long-Term Debt | 39.49B | 41.6B | 38.33B | 37.17B | 37.13B | 33.77B | 30.8B | 33.58B | 32.03B | 32.86B | 31.16B | 30.25B | 29.09B | 27.59B | 27.5B | 25.64B | 27.63B | 24.82B | 26.59B | 27B | 28.11B | 9.89B | 10.04B | 8.04B | 6.5B | 6.55B | 5.63B | 5.28B | 5.68B | 9.28B | 6.78B |
| Capital Lease Obligations | 7.39B | 1.85B | 1.86B | 1.9B | 2.33B | 2.33B | 1.67B | 1.5B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -125M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.72B | 1.61B | 1.77B | 1.78B | 1.38B | 1.02B | 1.41B | 1.75B | 1.65B | 999M | 0 | 0 | 0 | 0 | 0 | 2.1B |
| Other Non-Current Liabilities | 3.86B | 3.69B | 3.58B | 3.42B | 3.14B | 3.57B | 3.43B | 2.79B | 2.52B | 2.57B | 2.4B | 3.02B | 3.13B | 2.47B | 2.75B | 2.71B | 2.6B | 2.97B | 2.89B | 2.61B | 1.31B | 1.34B | 1.28B | 1.31B | 1.19B | 2.67B | 2.82B | 1.89B | 1.84B | 1.87B | 0 |
| Total Liabilities | 64.43B | 63.49B | 58.96B | 55.15B | 52.51B | 49.25B | 44.6B | 45.62B | 42.13B | 41.59B | 39.39B | 38.79B | 37.7B | 35.76B | 36.42B | 33.91B | 34.65B | 32.11B | 33.54B | 33.63B | 34.14B | 16.53B | 16.25B | 14.17B | 12.43B | 12.4B | 12.59B | 10.51B | 11.08B | 13.92B | 11.83B |
| Total Debt | 49.84B | 50.2B | 45.24B | 41.86B | 40.2B | 36.73B | 33.06B | 35.57B | 32.82B | 33.06B | 31.38B | 30.49B | 29.43B | 28.38B | 28.93B | 27.05B | 28.23B | 25.67B | 26.99B | 27.31B | 28.41B | 10.47B | 10.53B | 8.71B | 6.94B | 7.36B | 6.75B | 6.44B | 6.75B | 9.41B | 6.98B |
| Net Debt | 48.91B | 49.16B | 43.3B | 40.92B | 39.29B | 35.27B | 31.26B | 34.95B | 32.32B | 32.33B | 30.73B | 29.75B | 28.86B | 27.96B | 28.23B | 26.68B | 27.81B | 25.36B | 26.52B | 26.91B | 27.77B | 10.14B | 10.27B | 8.59B | 6.78B | 7.28B | 6.44B | 6.25B | 6.46B | 9.3B | 6.87B |
| Debt / Equity | -16.74x | - | 81.51x | 39.49x | - | 24.66x | 11.43x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.84x | 2.02x | 1.26x | 1.10x | 1.38x | 1.36x | 1.01x | 0.81x | 1.16x | 0.74x |
| Debt / EBITDA | 3.20x | 3.24x | 3.26x | 3.29x | 3.34x | 2.93x | 3.31x | 3.62x | 3.68x | 4.04x | 3.84x | 3.87x | 3.98x | 4.34x | 4.45x | 4.66x | 5.05x | 4.91x | 6.20x | 6.24x | 6.72x | 2.45x | 2.66x | 2.23x | 2.27x | 2.25x | 0.38x | 0.37x | 0.37x | 3.91x | 1.72x |
| Net Debt / EBITDA | 3.14x | 3.17x | 3.12x | 3.22x | 3.27x | 2.82x | 3.13x | 3.56x | 3.62x | 3.95x | 3.76x | 3.78x | 3.91x | 4.27x | 4.35x | 4.60x | 4.98x | 4.85x | 6.10x | 6.15x | 6.57x | 2.37x | 2.59x | 2.20x | 2.22x | 2.22x | 0.37x | 0.36x | 0.36x | 3.86x | 1.69x |
| Interest Coverage | 5.29x | 5.37x | 5.14x | 4.98x | 5.94x | 7.46x | 4.50x | 3.84x | 4.02x | 3.64x | 4.08x | 3.65x | 3.24x | 2.79x | 2.80x | 3.30x | 2.06x | 2.43x | 1.58x | 1.54x | 2.74x | 4.28x | 4.50x | - | - | - | - | - | - | - | - |
| Total Equity | -2.98B | -2.77B | 555M | 1.06B | -73M | 1.49B | 2.89B | -565M | -2.92B | -5B | -5.63B | -6.05B | -6.5B | -6.93B | -8.34B | -7.01B | -10.79B | -7.98B | -9.26B | -9.6B | -10.47B | 5.69B | 5.22B | 6.89B | 6.31B | 5.33B | 4.98B | 6.38B | 8.35B | 8.09B | 9.45B |
| Equity Growth % | -1746.33% | -599.28% | -47.64% | 1552.05% | -104.9% | -48.51% | 611.86% | 80.64% | 41.58% | 11.33% | 6.83% | 6.96% | 6.21% | 16.94% | -18.92% | 35.02% | -35.3% | 13.84% | 3.54% | 8.28% | -283.92% | 9.11% | -24.29% | 9.12% | 18.55% | 6.99% | -21.99% | -23.56% | 3.22% | -14.39% | 20.3% |
| Book Value per Share | -13.14 | -12.01 | 2.12 | 3.83 | -0.25 | 4.53 | 8.37 | -1.62 | -8.21 | -13.42 | -14.23 | -14.17 | -14.43 | -15.00 | -18.16 | -14.14 | -24.68 | -22.88 | -26.55 | -27.53 | -25.52 | 12.72 | 10.78 | 13.50 | 12.05 | 9.92 | 8.98 | 9.57 | 12.94 | 12.20 | 13.93 |
| Total Shareholders' Equity | -6.3B | -6.03B | -2.5B | -1.77B | -2.77B | -933M | 572M | -2.81B | -4.95B | -6.81B | -7.3B | -7.6B | -7.89B | -8.27B | -9.66B | -8.26B | -11.93B | -8.99B | -10.26B | -10.54B | -11.37B | 4.86B | 4.41B | 6.21B | 5.7B | 4.76B | 4.41B | 5.62B | 7.58B | 7.25B | 8.61B |
| Common Stock | 2M | 2M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 1M | 1M | 1M | 1M | 4M | 4M | 5M | 5M | 5M | 5M | 6M | 6M | 6M | 7M |
| Retained Earnings | -5.98B | -5.72B | -2.12B | -1.35B | -2.28B | -532M | 777M | -2.35B | -4.57B | -6.53B | -6.97B | -7.34B | -7.58B | -9.4B | -10.96B | -9.42B | -11.89B | -8.76B | -9.82B | -10.48B | -11.39B | 4.73B | 4.21B | 6.03B | 5.53B | 4.73B | 4.34B | 4.6B | 3.99B | 3.66B | 4.02B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -327M | -305M | -387M | -425M | -490M | -404M | -502M | -460M | -381M | -278M | -338M | -265M | -323M | -257M | -457M | -440M | -428M | -450M | -604M | -172M | 16M | 130M | 193M | 168M | 73M | 18M | 52M | 53M | 80M | 92M | -5.32B |
| Minority Interest | 3.33B | 3.26B | 3.05B | 2.83B | 2.69B | 2.42B | 2.32B | 2.24B | 2.03B | 1.81B | 1.67B | 1.55B | 1.4B | 1.34B | 1.32B | 1.24B | 1.13B | 1.01B | 995M | 938M | 907M | 828M | 809M | 680M | 611M | 563M | 572M | 763M | 765M | 836M | 836M |
Negative equity and leverage
As reported in recent financial filings, HCA's total equity has deteriorated into a negative position of $6.3B by 2026Q1, a significant decline from the $1.8B deficit observed in 2023Q4, signaling a potential long-term weakening of the company's net asset position relative to its total liabilities.
The consistent decline in equity appears to be driven by aggressive capital allocation policies, specifically share repurchases, which have outpaced retained earnings growth. Investors should monitor whether this trend of negative equity persists, as it may indicate that the company is effectively leveraging its balance sheet to support valuation rather than building intrinsic book value.
Based on the provided balance sheet data, HCA's total debt has climbed to $49.8B in 2026Q1 from $41.9B in 2023Q4, reflecting a persistent reliance on external financing to fund both operational requirements and ongoing capital expenditures across its regional hospital clusters.
The steady accumulation of debt suggests that the company is prioritizing expansion and shareholder returns over deleveraging, even as interest rate environments remain uncertain. This debt-heavy structure warrants further investigation into the maturity profile and the potential for refinancing risk if cash flow generation from core hospital operations continues to face margin pressure.
According to quarterly balance sheet disclosures, HCA's net property, plant, and equipment (PPE) has grown to $33.6B in 2026Q1, up from $29.9B in 2023Q4, confirming the company's commitment to maintaining its extensive physical footprint despite the ongoing shift toward outpatient care models.
The growth in PPE relative to total assets underscores the capital-intensive nature of the hospital business, where maintaining high-acuity facilities is essential to the cluster strategy. However, the rising asset base requires consistent, high-margin throughput to justify the depreciation and maintenance costs, which may be increasingly difficult to achieve in a competitive reimbursement landscape.
As indicated by recent financial statements, HCA's current ratio has compressed to 0.83 in 2026Q1 from a peak of 1.18 in 2023Q4, suggesting a narrowing margin of safety for meeting short-term obligations amidst fluctuating working capital requirements and ongoing operational cost pressures.
The decline in the current ratio appears to reflect a reduced cash buffer, which may limit the company's flexibility to respond to unexpected regulatory or operational shocks. This tightening liquidity profile warrants close monitoring, as it suggests that the company is operating with less room for error in its day-to-day cash management.
Quick answers to the most common questions about buying HCA stock.
As of 2025, HCA Healthcare, Inc. (HCA) had total assets of $60.72B including $13.56B in current assets.
HCA Healthcare, Inc. (HCA) carries total debt of $50.20B, offset by $1.04B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
HCA Healthcare, Inc. (HCA) has total shareholders' equity (book value) of $-6027.0M ($-12.01 book value per share). Book value represents the net worth of the company belonging to common stock holders.
HCA Healthcare, Inc. (HCA) reported a current ratio of 0.83x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.